Abrams michael j - direct investment history in Arbutus biopharma corp

Filed on 2016-08-18 by Abrams Michael J. SEC CIK 1628291 Form 4

Accession 0001140361-16-077194.txt Sec File: edgar/data/1628291/0001140361-16-077194-index.htm

2016-08-16 Abrams Michael J (CIK 1628291) through Direct (Managing Director)

Invested in Arbutus Biopharma Corp bought 13503 shares at $0 remaining shares owned 0

Employee Stock Option Right To Buy Arbutus Biopharma Corp Abus exercise date 2008-03-30 exercise price 0.3455 has valueitem expiration due date 2017-05-27 underlying security shares 13503 underlying security title Common Shares

f1 the options were exeercisable at cdn$0.4444; exercise price references above was converted into u.s. dollars using an exchange rate of cdn$1.2862=us$1.00.


Filed on 2016-08-18 by Abrams Michael J. SEC CIK 1628291 Form 4

Accession 0001140361-16-077194.txt Sec File: edgar/data/1628291/0001140361-16-077194-index.htm

2016-08-16 Abrams Michael J (CIK 1628291) through Direct (Managing Director)

Invested in Arbutus Biopharma Corp bought 675 shares at $0 remaining shares owned 0

Employee Stock Option Right To Buy Arbutus Biopharma Corp Abus exercise date 2008-03-30 exercise price 0.3455 has valueitem expiration due date 2017-04-03 underlying security shares 675 underlying security title Common Shares

f1 the options were exeercisable at cdn$0.4444; exercise price references above was converted into u.s. dollars using an exchange rate of cdn$1.2862=us$1.00.


Filed on 2016-08-18 by Abrams Michael J. SEC CIK 1628291 Form 4

Accession 0001140361-16-077194.txt Sec File: edgar/data/1628291/0001140361-16-077194-index.htm

2016-08-16 Abrams Michael J (CIK 1628291) through Direct (Managing Director)

Invested in Arbutus Biopharma Corp bought 14178 shares at $0.3455 remaining shares owned 42097

Common Shares Arbutus Biopharma Corp Abus Transaction code: M Exercise or conversion of derivative security

f1 the options were exeercisable at cdn$0.4444; exercise price references above was converted into u.s. dollars using an exchange rate of cdn$1.2862=us$1.00.


Filed on 2016-03-17 by Abrams Michael J. SEC CIK 1628291 Form 4

Accession 0001140361-16-058177.txt Sec File: edgar/data/1628291/0001140361-16-058177-index.htm

2016-03-15 Abrams Michael J (CIK 1628291) through Direct (Managing Director)

Invested in Arbutus Biopharma Corp bought 50000 shares at $0.0 remaining shares owned 50000

Employee Stock Option Right To Buy Arbutus Biopharma Corp Abus exercise price 3.94 has valueitem expiration due date 2026-03-15 underlying security shares 50000 underlying security title Common Shares

f1 the options vest as follows: 1/3 on march 15, 2017; 1/3 on march 15, 2018; and 1/3 on march 15, 2019.


Filed on 2016-01-06 by Abrams Michael J. SEC CIK 1628291 Form 4/a

Accession 0001140361-16-046992.txt Sec File: edgar/data/1628291/0001140361-16-046992-index.htm

2015-07-09 Abrams Michael J (CIK 1628291) through Direct (Managing Director)

Invested in Arbutus Biopharma Corp bought 35000 shares at $0 remaining shares owned 35000

Employee Stock Option Right To Buy Arbutus Biopharma Corp Abus exercise price 17.57 has valueitem expiration due date 2025-03-30 underlying security shares 35000 underlying security title Common Shares

f1 the option vests as follows: 1/3 on 3/30/2016; 1/3/ on 3/30/2017; and 1/3 on 3/30/2018.


Filed on 2015-12-22 by Abrams Michael J. SEC CIK 1628291 Form 4

Accession 0001140361-15-045390.txt Sec File: edgar/data/1628291/0001140361-15-045390-index.htm

2015-07-09 Abrams Michael J (CIK 1628291) through Direct (Exec Vp Chief Discovery Off)

Invested in Arbutus Biopharma Corp bought 35000 shares at $0 remaining shares owned 35000

Employee Stock Option Right To Buy Arbutus Biopharma Corp Abus exercise price 17.57 has valueitem expiration due date 2025-03-30 underlying security shares 35000 underlying security title Common Shares

f1 the option vests as follows: 1/3 on 3/30/2016; 1/3/ on 3/30/2017; and 1/3 on 3/30/2018.


Filed on 2015-09-15 by Abrams Michael J. SEC CIK 1628291 Form 4

Accession 0001140361-15-035076.txt Sec File: edgar/data/1628291/0001140361-15-035076-index.htm

2015-09-11 Abrams Michael J (CIK 1628291) through Direct (Managing Director)

Invested in Arbutus Biopharma Corp sold 17044 shares at $0.0 remaining shares owned 0

Employee Stock Option Right To Buy Arbutus Biopharma Corp Tkmr exercise date 2008-03-30 exercise price 0.4444 has valueitem expiration due date 2015-09-12 underlying security shares 17044 underlying security title Common Shares

f1 expressed in canadian dollars.


Filed on 2015-09-15 by Abrams Michael J. SEC CIK 1628291 Form 4

Accession 0001140361-15-035076.txt Sec File: edgar/data/1628291/0001140361-15-035076-index.htm

2015-09-11 Abrams Michael J (CIK 1628291) through Direct (Managing Director)

Invested in Arbutus Biopharma Corp bought 17044 shares at $0.4444 remaining shares owned 27919

Common Shares Arbutus Biopharma Corp Tkmr Transaction code: M Exercise or conversion of derivative security

f1 expressed in canadian dollars.